As a global enterprise with a diversified portfolio, the Bayer Group is exposed to a wide range of internal and external developments and events that could significantly impact the achievement of our financial and nonfinancial objectives.
Opportunity and risk management at Bayer forms an integral part of the Group-wide corporate governance system. Our opportunity and risk management process and opportunity and risk status are outlined in detail in the Annual Report 2025, A 3.2 “Opportunity and Risk Report.”
Overall assessment by the Board of Management
We currently have not identified any material changes in our risk status compared with the assessment given in the Annual Report 2025. In the opinion of the Board of Management, the Bayer Group’s continued existence remains unendangered.
Significant developments that have occurred in respect of the legal risks since publication of the Annual Report 2025 (Note [30] to the Consolidated Financial Statements) are described in the Notes to the Condensed Consolidated Interim Financial Statements under “Legal Risks.”